Skip to main content
UTSouthwestern Medical Center Logo
  • UTSouthwestern Medical Center Logo
  • Specialties
      • Featured Specialties
      • Cancer
      • Diabetes & Endocrinology
      • Gastroenterology and GI Surgery
      • Geriatric Medicine
      • Cardiology, Heart & Vascular Surgery
      • Neurology & Neurosurgery
      • Obstetrics & Gynecology
      • Ophthalmology
      • Orthopaedics
      • Otolaryngology
      • Psychiatry
      • Physical Medicine & Rehabilitation
      • Pulmonology & Lung Surgery
  • Resources for Physicians
      • Refer a Patient
      • UTSWMyCare
      • EpicCare Link
      • Clinical Trials
      • CME Courses
      • Physician Outreach
  • Resources for Your Patients
      • Find a Physician
      • UTSWMyCare
      • Locations

Robert Collins, MD

Professor, Internal Medicine
Director, Blood Cancers Program, Transplant and Cellular Therapies Program, Combined Adult/Pediatric Stem Cell Transplant Program

Robert Collins, MD

Robert H. Collins Jr., M.D., FACP, is a Professor of Internal Medicine and Director of both the Blood Cancers / Transplant and Cellular Therapies Program and the Combined Adult/Pediatric Stem Cell Transplant Program at UT Southwestern Medical Center.

He holds the Sydney and J.L. Huffines Distinguished Chair in Cancer Research in Honor of Eugene Frenkel, M.D., and is the R. Lloyd and Willye V. Skaggs Professor in Medical Research.

A recognized leader in the field of adoptive immunotherapy, Dr. Collins specializes in blood and marrow transplantation and hematologic malignancies such as leukemia, lymphoma, myeloma, Hodgkin’s disease, and myelodysplasia.

Dr. Collins earned his medical degree from the University of Missouri-Kansas City School of Medicine. He completed an internal medicine residency at Baylor University Medical Center in Dallas, as well as a fellowship in hematology and oncology at the University of California at Los Angeles.

Board-certified in internal medicine and medical oncology, Dr. Collins has 25 years of experience in bone marrow transplantation and has participated in some 2,500 autologous and allogeneic transplants.

He is a Fellow of the American College of Physicians and a member of numerous scientific and medical organizations, including the American Association for the Advancement of Science, the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Blood and Marrow Transplantation.

Dr. Collins has led studies of donor leukocyte infusions through an international network of more than 100 centers. He continues to lead an active program of phase I-III clinical trials investigating novel approaches to hematologic malignancies and blood and marrow transplantation.

He has been named a U.S.News & World Report Best Doctor, and is listed in Best Doctors in America, and Texas Monthly Super Doctors. He was included in D Magazine's Best Doctors list for 2021. 

Dr. Collins is a recipient of the John J. Kenny Award from the Leukemia & Lymphoma Society and has been honored with a number of other recognitions.

View full profile


Related Videos

CAR T-Cell Therapy Fights Cancer with a Live Weapon Video

CAR T-Cell Therapy Fights Cancer with a Live Weapon

By harnessing the full force of a patient's immune system, the targeted approach of CAR T-cell therapy makes it possible to mount a highly effective attack against certain cancers.


Powered by BroadcastMedBROADCASTMED

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty members have received six Nobel Prizes and include 25 members of the National Academy of Sciences, 24 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 3,200 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 120,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 5 million outpatient visits a year.